News & Announcements


The Sydney Addiction Seminars are a post-graduate health education series now held under the auspices of Drug Health Services, Royal Prince Alfred Hospital, and the Department of Addiction Medicine, University of Sydney. They are convened by Dr Richard Hallinan and Professor Paul Haber.

UPCOMING SEMINAR


Wednesday 23rd November, 2016

"Paradigm shift in the management of the alcohol intoxicated frequent flyer."


Patients with repeated presentation for alcohol intoxication to hospitals are a major challenge and drain on health resources. Can we do more than just an offer to sober up in ED? How does capacity assessment shift the care paradigm and health outcomes? These issues will be explored with case studies and a literature scan. With an emphasis on alcohol related cognitive impairment and the interface of addiction medicine with psychiatric services.



Presenter: Dr Nghi Phung is Director of Drug Health, Western Sydney Local Health District, and Senior Staff Specialist in Addiction Medicine, and in Gastroenterology and Hepatology, at Westmead Hospital




We aim to make these seminars as interactive as possible. Please email your suggestions to for cases and questions to Richard Hallinan at reichall@imprimus.com.au


The Sydney Addiction Seminars will hosted again this year by Drug Health Services, RPAH, and held in the Scott Skirving Theatre from 7pm-9pm on Wednesday evenings as per the programme below.

There will be four seminars this year, presented by experts from four Local Health Districts. Participation will now also be possible by webinar for those who cannot attend in person.


Venue: Scott Skirving Theatre, RPAH, Camperdown
Webinar: Register


6.30pm for introductions and refreshments, sessions starts at 7pm. No booking necessary, but to assist with catering please RSVP interest to abbie.white@sydney.edu.au or call Drug Health Services RPAH on 02 9515 6419


This seminar series attracts 2 points/hour for RACGP QA&CPD (activity number 715352).

The sessions and refreshments are again supported this year by Reckitt Benckiser, makers of buprenorphine and buprenorphine/naloxone